首页> 外国专利> For the program and equipment of the production that the woven composite arrangement of reinforcement main body and TOPIC in space are obtained by program

For the program and equipment of the production that the woven composite arrangement of reinforcement main body and TOPIC in space are obtained by program

机译:对于生产程序和设备,通过程序获得增强主体和TOPIC在空间上的编织复合布置

摘要

The present invention relates to the compound of a chemical formula I or one pharmaceutically acceptable salt,Wherein 1 R 2 of Z or 1 or NR, wherein each R 1 and R 2 are independently H or a hydrocarbyl group; X is an olefin(e), alkenylene or alkynylene, each can optionally be replaced by one or more substituent groups selected from alkyl, COOH, CO 2- alkyl, alkenyl, CN, NH 2, hydroxyl, halation, alkoxy, CF 3 and nitro; Y is the polar functional group selected from OH, 2 numbers CN, 2 NR of COR 3, COOR 3, NR 3 R 4, CONR 3 R 4, SO 3 H, SO 2-R 3, SO, 3 R 4 and CF 3, wherein each R 3 and R 4 are independently H or a hydrocarbyl group; A is an aryl or heterocycle, each can selectively be substituted; WithB is (CH 2) n, and wherein n is 0,1,2,3,4 or 5; Condition:(i) when A is phenyl, n is 0, Z is OH, does is X-Y different from member C ‰? 2 H of C (CH 2) 2 CO, first C ‰? C (CH 2) 2 OH, first C ‰? 2 Me, meta-(CH 2 of C (CH 2) 2 CO) 4 CO, 2 H, 2 CO of n- CH, 2 H, n- 2 H of (CH 2) 2 CO and n- 2 H of (CH 2) 4 CO; WithDoes is (ii) n that 0, Z is OMe, and X-Y is different from member C ‰ when A is phenyl? 4 OH of C (CH 2). Other each aspect of the present invention is related to using for treating a muscular disorder, a gastrointestinal disorder, or such compound in a kind of preparation process of medicament for controlling spasticity or vibration.
机译:本发明涉及化学式I的化合物或一种药学上可接受的盐,其中Z为1的R 2或NR为1,其中R 1和R 2各自独立地为H或烃基; X是烯烃(e),亚烯基或亚炔基,各自可以任选地被一个或多个选自烷基,COOH,CO 2-烷基,烯基,CN,NH 2,羟基,卤代,烷氧基,CF 3和C 1的取代基取代。硝基Y是选自OH,2个CN,2个NR的COR 3,COOR 3,NR 3 R 4,CONR 3 R 4,SO 3 H,SO 2-R 3,SO,3 R 4和CF的极性官能团3,其中R 3和R 4各自独立地为H或烃基;A是芳基或杂环,各自可以被选择性地取代;用B为(CH 2)n,其中n为0、1、2、3、4或5;健康)状况:(i)当A为苯基,n为0,Z为OH时,X-Y与C成员是否不同? C(CH 2)2 CO的2 H,第一个C‰? C(CH 2)2 OH,第一个C‰? 2 Me,间-(C(CH 2)2 CO的CH 2),2 H,n-CH的2 CO,(CH 2)2 CO的2 H,n- 2 H和(CH 2)的n-2 H (CH 2)4 CO;用(ii)当A为苯基时,n是否为0,Z为OMe和X-Y与C成员不同? C(CH 2)为4 OH。本发明的其他各方面涉及在一种用于控制痉挛或振动的药物的制备过程中用于治疗肌肉疾病,胃肠道疾病或此类化合物的用途。

著录项

  • 公开/公告号NO20064227L

    专利类型

  • 公开/公告日2006-11-16

    原文格式PDF

  • 申请/专利权人 UNIVERSITY COLLEGE LONDON;

    申请/专利号NO20060004227

  • 申请日2006-09-19

  • 分类号C07C233/68;A61K31/167;A61K31/192;A61K31/216;C07C63/04;C07C69/76;C07C69/78;C07C233/11;C07C233/65;C07C233/66;C07C233/69;C07C233/77;C07C235/42;C07C235/78;C07C235/84;C07C237/32;C07C237/38;C07C237/42;C07C255/41;

  • 国家 NO

  • 入库时间 2022-08-21 20:56:56

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号